Applied Therapeutics Cash and Cash Equivalents 2011-2026 | APLT

Annual Cash and Cash Equivalents Applied Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
49.9 M	16.7 M	53.9 M	57.5 M	18.8 M	18.7 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
57.5 M	16.7 M	35.9 M

Quarterly Cash and Cash Equivalents Applied Therapeutics

2025-Q3	2025-Q2	2024-Q4	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
11.9 M	30.4 M	79.4 M	98.9 M	122 M	49.9 M	37.5 M	35.6 M	22.9 M	16.7 M	40.4 M	55.7 M	38.2 M	53.9 M	70.2 M	78.4 M	84.1 M	57.5 M	57.5 M	57.5 M	57.5 M	18.8 M	18.8 M	18.8 M	18.8 M	18.7 M	18.7 M	18.7 M	18.7 M	3.28 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
122 M	3.28 M	43.7 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
Anika Therapeutics ANIK	72.9 M	$ 14.44	1.12 %	$ 212 M	USA
Aeterna Zentaris AEZS	16.4 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	12.9 M	-	10.36 %	$ 9.8 M	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	616 M	$ 221.82	2.91 %	$ 5 B	Danmark
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	170 M	$ 19.58	1.79 %	$ 915 M	USA
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
BioMarin Pharmaceutical BMRN	1.31 B	$ 55.14	1.94 %	$ 10.6 B	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	345 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
Atreca BCEL	30.8 M	-	-11.76 %	$ 5.79 M	USA
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	4.55 B	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	222 M	-	-	$ 546 M	USA
Cara Therapeutics CARA	51.8 M	-	-3.03 %	$ 260 M	USA
Adverum Biotechnologies ADVM	60.7 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	2.33 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
Avenue Therapeutics ATXI	2.59 M	-	-52.27 %	$ 4.45 M	USA
CNS Pharmaceuticals CNSP	6.46 M	$ 2.81	3.69 %	$ 1.07 M	USA
Autolus Therapeutics plc AUTL	240 M	$ 1.36	2.65 %	$ 347 M	Britain
Corbus Pharmaceuticals Holdings CRBP	28.5 M	$ 8.35	2.02 %	$ 111 M	USA
CRISPR Therapeutics AG CRSP	348 M	$ 47.75	2.84 %	$ 4.29 B	Schweiz
Cyclacel Pharmaceuticals CYCC	3.14 M	-	-5.98 %	$ 34.1 M	USA
CytomX Therapeutics CTMX	12.7 M	$ 4.43	4.36 %	$ 611 M	USA
ChemoCentryx CCXI	50 M	-	-	$ 3.74 B	USA
Dynavax Technologies Corporation DVAX	95.9 M	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	112 M	-	-4.8 %	$ 255 M	USA
Enochian Biosciences ENOB	92.7 K	-	-	$ 40.5 M	USA
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
Eton Pharmaceuticals ETON	25.9 M	$ 24.19	5.29 %	$ 651 M	USA
Bellerophon Therapeutics BLPH	6.92 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	18 M	$ 4.58	6.26 %	$ 878 M	Canada
Homology Medicines FIXX	48.3 M	-	0.77 %	$ 53.4 M	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	4.08 M	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	66.4 M	-	-	$ 28.6 M	USA